Insider Trading & Ownership - Hagan Joseph P

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Hagan Joseph P
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-18
Sale
2024-01-18
8:22 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
Chief Executive Officer
14,580$1.1906$17,35957,112
(Direct)
View
2023-05-19
Sale
2023-05-23
5:18 pm
Aurinia Pharmaceuticals Inc.AUPHHagan Joseph P
Director
272$10.58$2,87811,961
(Direct)
View
2022-01-26
Purchase
2022-01-26
4:13 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
100,000$0.2152$21,5202,017,006
(Direct)
View
2022-01-03
Sale
2022-01-04
4:17 pm
Aurinia Pharmaceuticals Inc.AUPHHagan Joseph P
Director
40,000$22.59$903,65013,500
(Direct)
View
2021-05-17
Sale
2021-05-17
7:13 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
4,186$0.89$3,726316,292
(Direct)
View
2021-02-16
Sale(A)
2021-04-16
4:11 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
4,144$1.72$7,128244,628
(Direct)
View
2021-02-16
Sale
2021-02-17
5:23 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
4,144$1.72$7,128485,756
(Direct)
View
2020-11-16
Sale
2020-11-18
4:09 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
6,094$0.5211$3,176215,994
(Direct)
View
2020-08-14
Sale
2020-08-17
8:22 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
4,245$0.6049$2,568222,088
(Direct)
View
2020-05-15
Sale
2020-05-18
4:28 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
4,426$0.6267$2,774226,333
(Direct)
View
2020-02-18
Sale
2020-02-19
6:09 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
4,324$0.8304$3,591230,759
(Direct)
View
2020-01-02
Sale
2020-01-03
4:07 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
8,345$0.9667$8,067235,083
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-20
Option Award
2024-05-21
4:21 pm
N/A
2034-05-19
Regulus Therapeutics Inc.RGLSHagan Joseph P
Chief Executive Officer
990,000$0990,000
(Direct)
View
2024-01-12
Option Award
2024-01-17
5:16 pm
N/A
2034-01-11
Regulus Therapeutics Inc.RGLSHagan Joseph P
Chief Executive Officer
279,000$0320,692
(Direct)
View
2023-08-10
Option Award
2023-08-14
4:17 pm
N/A
2033-08-09
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
1,312,500$01,312,500
(Direct)
View
2023-05-18
Exercise
2023-05-23
5:18 pm
2023-05-18
N/A
Aurinia Pharmaceuticals Inc.AUPHHagan Joseph P
Director
8,733$011,961
(Direct)
View
2023-01-11
Option Award
2023-01-17
4:11 pm
N/A
2033-01-10
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
100,000$0100,000
(Direct)
View
2022-05-18
Option Award
2022-05-20
4:07 pm
N/A
N/A
Aurinia Pharmaceuticals Inc.AUPHHagan Joseph P
Director
23,345$023,345
(Direct)
View
2022-05-10
Option Award
2022-05-11
4:54 pm
N/A
2030-01-20
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
300,000$0300,000
(Direct)
View
2022-01-12
Option Award
2022-01-26
4:13 pm
N/A
2032-01-11
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
1,600,000$02,017,006
(Direct)
View
2022-01-03
Exercise
2022-01-04
4:17 pm
N/A
2028-02-08
Aurinia Pharmaceuticals Inc.AUPHHagan Joseph P
Director
40,000$013,500
(Direct)
View
2022-01-03
Exercise
2022-01-04
4:17 pm
N/A
N/A
Aurinia Pharmaceuticals Inc.AUPHHagan Joseph P
Director
40,000$5.0813,500
(Direct)
View
2021-06-14
Option Award
2021-06-16
9:23 pm
N/A
2031-06-14
Aurinia Pharmaceuticals Inc.AUPHHagan Joseph P
Director
31,347$031,347
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:31 pm
N/A
2031-06-09
Zosano Pharma CorpZSANHagan Joseph P
Director
45,000$052,500
(Direct)
View
2021-04-14
Conversion
2021-04-16
4:12 pm
N/A
N/A
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
83,435$0320,478
(Indirect)
View
2021-02-04
Option Award
2021-02-05
5:01 pm
N/A
2031-02-04
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
600,000$0600,000
(Direct)
View

Ownership
2021-01-04
5:56 pm
N/A
N/A
Aurinia Pharmaceuticals Inc.AUPHHagan Joseph P
Director
0$0128,500
(Direct)
View
2020-12-04
Option Award
2020-12-07
4:22 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
29,760$0.125255,434
(Indirect)
View
2020-12-04
Option Award
2020-12-07
4:22 pm
N/A
N/A
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
39,680$0.6301255,434
(Indirect)
View
2020-06-25
Option Award
2020-06-29
9:54 pm
N/A
N/A
Zosano Pharma CorpZSANHagan Joseph P
Director
7,500$07,500
(Direct)
View
2020-06-03
Option Award
2020-06-05
5:05 pm
N/A
2030-06-02
Zosano Pharma CorpZSANHagan Joseph P
Director
15,000$015,000
(Direct)
View
2020-01-22
Option Award
2020-01-24
4:13 pm
N/A
2030-01-21
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
900,000$0900,000
(Direct)
View
2019-12-24
Option Award
2019-12-26
08:50 am
2019-12-24
2024-12-24
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
75,850$0.12583,435
(Indirect)
View
2019-12-24
Option Award
2019-12-26
08:50 am
N/A
N/A
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
7,585$6.6683,435
(Indirect)
View
(A) Indicate amendment filing.